Skip to main content
. Author manuscript; available in PMC: 2024 Mar 19.
Published in final edited form as: Neurocrit Care. 2022 Jan 31;37(1):81–90. doi: 10.1007/s12028-022-01444-z

Table 2.

Clinical outcomes following aneurysmal subarachnoid hemorrhage, according to development of radiographic spasm.

Variable (−) Vasospasm N=219 (+) Vasospasm N=309 Combined N=528 P-value
Censored (days) 21 (21–21) 6.0 (4–8) 9 (5–21) <0.0011
Hospital Mortality 33 (15%) 40 (13%) 73 (14%) 0.492
DCI 12 (5%) 32 (10%) 44 (8%) 0.0272
MRI not obtained 196 (89%) 250 (81%) 446 (84%)
Discharge mRS <0.0012
 1 36 (16%) 21 (7%) 57 (11%)
 2 33 (15%) 32 (10%) 65 (12%)
 3 49 (22%) 67 (22%) 116 (22%)
 4 49 (22%) 122 (39%) 171 (32%)
 5 14 (6%) 22 (7%) 36 (7%)
 6 33 (15%) 40 (13%) 73 (14%)
 Missing 5 (2%) 5 (2%) 10 (2%)
Discharge Disposition 0.0472
 Home 108 (49%) 122 (29%) 230 (44%)
 Rehabilitation Facility 49 (22%) 93 (30%) 142 (27%)
 Skilled Nursing Facility 20 (9%) 36 (12%) 56 (11%)
 Long-term Acute Care 3 (1%) 10 (3%) 13 (2%)
 Hospice 0 (0%) 3 (1%) 3 (1%)
 NA 39 (18%) 45 (15%) 84 (16%)

Continuous variables listed as median (IQR), categorical variables as n (%).

Tests used:

1

Wilcoxon test;

2

Pearson test.

DCI: delayed cerebral ischemia; mRS: modified Rankin scale; NA: not applicable